Washington University School of Medicine

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Washington University School of Medicine sits in the top decile of US sponsors by registered trial count (#12 of 15,742 sponsors by registered trial count).

1,502 total trials 214 currently recruiting 919 completed early-phase tilt top decile by trial count

Washington University School of Medicine: 1,502 sponsored US clinical trials, 214 recruiting.

Washington University School of Medicine sponsors 1,502 registered US clinical trials on ClinicalTrials.gov, 214 of them currently recruiting, and 919 completed. 98 of these trials are in Phase 3-4 (later-stage) and 569 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 20 trials.

Top-decile sponsor footprint

Washington University School of Medicine ranks in the top decile of sponsors by registered trial count (#12 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 38/100

919 of 1,159 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (79.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

1,502 total, page 13 of 31

COMPLETED Phase 1

Liposomal Irinotecan Plus 5-FU / LV Combined With Paricalcitol in Patients With Advanced Pancreatic Cancer Progressed on Gemcitabine-based Therapy

NCT03883919
COMPLETED NA

Collaborative Organizational Approach to Selecting and Tailoring Implementation Strategies

NCT03799432
COMPLETED NA

Comparison of Movement Pattern Training and Manual Therapy for Prearthritic Hip Disorders

NCT03959319
COMPLETED Phase 3

Telemedicine Control Tower for the Operating Room: Navigating Information, Care and Safety

NCT03923699
COMPLETED Phase 2

Magnetic Resonance-Guided Hypofractionated Adaptive Radiation Therapy With Concurrent Chemotherapy and Consolidation Durvalumab for Inoperable Stage IIB, IIIA, and Select IIIB and IIIC Non-small Cell Lung Cancer

NCT03916419
COMPLETED Phase 2

Preeclampsia And Nonsteroidal Drugs for Analgesia: a Randomized Non Inferiority Trial

NCT03978767
COMPLETED NA

PET MYOCARDIAL Blood Flow Comparison to Coronary CTA and CT-FFR

NCT05349084
COMPLETED Phase 2

Ramucirumab and Atezolizumab After Progression on Any Immune Checkpoint Blocker in NSCLC

NCT03689855
COMPLETED NA

Longitudinal Mindfulness Intervention to Decrease Burnout in Medical Residents

NCT04584268
TERMINATED Phase 1

Abemaciclib + Nivolumab in Patients With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma That Progressed or Recurred Within Six Months After Platinum-based Chemotherapy

NCT03655444
COMPLETED

Pharmacokinetics of Oxytocin at Cesarean Delivery

NCT03898882
COMPLETED

Potassium Flux in Hemodialysis Patients

NCT04287010
COMPLETED NA

Contraception Initiation Feasibility in the Pediatric ED

NCT03559634
TERMINATED Phase 1

Pgp Transporter and CNS Biodistribution of Ondansetron in Healthy Volunteers

NCT03809234
COMPLETED Phase 2

Smell Changes & Efficacy of Nasal Theophylline

NCT03990766
TERMINATED NA

TraceIT Tissue Marker to Mark the Primary Resection Bed Margins of Oropharyngeal Cancers

NCT03713021
COMPLETED Phase 1

Sinemet for Spasticity and Function in Amyotrophic Lateral Sclerosis and Primary Lateral Sclerosis

NCT03929068
TERMINATED NA

Hand-carried Ultrasound to Assess Hydronephrosis

NCT03774719
TERMINATED NA

Therapeutic Targeting of Sex Differences in Pediatric Brain Tumor Glycolysis

NCT03591861
COMPLETED NA

Same-session MR-only Simulation and Treatment With MRI-guided Adaptive Palliative RadioTherapy

NCT03824366
COMPLETED NA

Lung Cancer Screening Protocol

NCT03958253
TERMINATED NA

ECG for Programming in CRT

NCT03936608
COMPLETED NA

Removing Home Hazards for Older Adults in Affordable Housing

NCT03780777
COMPLETED NA

Feasibility of Exercise and Spinal Cord Injury

NCT03941600
COMPLETED

Study to Evaluate Amyloid in Blood and Imaging Related to Dementia

NCT03899844
COMPLETED NA

e-Mindfulness for Depression in Older Adults

NCT03922217
COMPLETED Phase 4

Effects of Microplegia on Transfusion Rates After Cardiac Surgery

NCT05076604
COMPLETED NA

Randomized Controlled Trial of Vaginal Cryotherapy for Pelvic Floor Myofascial Pain

NCT03885791
COMPLETED NA

Music and Local Anesthesia During Dermatologic Procedures

NCT04317170
COMPLETED NA

Cognition and Magnetic Resonance Imaging of Brain Inflammation in Obesity

NCT04116229
TERMINATED Phase 2

PROactive Evaluation of Function to Avoid CardioToxicity

NCT03862131
COMPLETED

Falls: A Marker of Preclinical AD

NCT04949529
COMPLETED NA

Diagnostic US for Reduction of Benign Breast Biopsies Using US-guided Optical Tomography

NCT03842358
COMPLETED Phase 3

Starting a Testosterone and Exercise Program After Hip Injury

NCT02938923
TERMINATED Phase 4

Hospital Avoidance Strategies for ABSSSI

NCT03372941
COMPLETED Phase 1

Study of IV VTS-270 for Infantile Liver Disease Associated With Niemann-Pick Disease, Type C

NCT03471143
COMPLETED NA

Effect of Pea Fiber Supplementation on the Gut Microbiota and Host Metabolome and Proteome (FIB)

NCT04159259
COMPLETED

UKA Manual Versus UKA MAKO Robotic

NCT03447626
COMPLETED NA

Liver Health and Metabolic Function in People With Obesity

NCT03701828
COMPLETED Phase 4

Antibiotic Elution in Total Knee Arthroplasty

NCT03928522
COMPLETED Phase 3

Healthy Eating and Active Living Taught at Home (HEALTH) Dissemination & Implementation (D&I)

NCT03758638
COMPLETED Phase 1

TUDCA as a Therapy for Ulcerative Colitis (UC)

NCT04114292
TERMINATED NA

Repetitive TMS & Cognitive Training in Adults With Schizophrenia

NCT03741751
TERMINATED NA

Remote Telemonitoring to Improve Prehabilitation and Surgical Outcomes of Patients Undergoing Elective Abdominal Surgery

NCT03706963
TERMINATED Phase 2

Pulsed Abraxane and Radiotherapy for Improving and Maintaining Ambulation After Cancer-Related Cord Compression

NCT03655080
COMPLETED Phase 1

CCR2 PET for Pancreatic Cancer Imaging and Prediction of Response to Standard and CCR2-Targeted Therapy

NCT03851237
COMPLETED Phase 4

Effectiveness of Mometasone Nasal Irrigation for Chronic Rhinosinusitis

NCT03705793
COMPLETED NA

Promoting Physical Activity in Rural Communities

NCT03683173
COMPLETED

Connectomics in Psychiatric Classification

NCT03967535
COMPLETED NA

The Role of Subscapularis Repair in Reverse Shoulder Arthroplasty

NCT03727490
← Previous Page 13 of 31 Next →

Phase Distribution

PhaseTrial count
Phase 1 332
Phase 2 237
Phase 3 40
Phase 4 58

Therapeutic Areas

Obesity 20
Breast Cancer 19
Multiple Myeloma 13
Myelodysplastic Syndromes 13
Alzheimer Disease 10
Parkinson Disease 8
Depression 8
Cancer of the Breast 7
Dementia 7
Insulin Resistance 7

What is open in the Washington University School of Medicine pipeline

214 recruiting of 1,502 indexed (14% open); 919 completed (61%).

Phase mix: 98 late (III/IV) vs 569 early (I/II) (early-phase heavy).

Top condition: Obesity (20 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Washington University School of Medicine: open-pipeline peers nationwide

Peers matched on 1,502 registered trials and 14% open enrollment, not the therapeutic-area sidebar.

Washington University School of Medicine sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05001,0001,5002,000 5%10%15%20% Total trials Recruiting share Washington University School of MedicineYale UniversityJohns Hopkins UniversityUniversity of PennsylvaniaNovartis PharmaceuticalsAcademic and Community Cancer Research UnitedAdaptive BiotechnologiesAgelessRxAlaska Blind Child Discovery
Washington University School of Medicine sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Washington University School of Medicine sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 1,502 trials (± recruiting share)

Sponsors near 14% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Washington University School of Medicine page

1,502 registered trials is a research-attention snapshot, not an endorsement of Washington University School of Medicine or any single study.

  • 214 of Washington University School of Medicine's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Obesity is the condition Washington University School of Medicine studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Washington University School of Medicine pipeline card: 1,502 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.